In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth

Laura Conti, Gabriella Regis, Angela Longo, Paola Bernabei, Roberto Chiarle, Mirella Giovarelli, Francesco Novelli

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Several approaches to target insulin-like growth factor-1 (IGF-1) signaling have resulted in the inhibition of the growth of a broad range of tumor cells. Malignant T cells are insensitive to the antiproliferative effects of the interferon-γ (IFN-γ)/signal transducer and activator of transcription 1 (STAT1) pathway because of the IGF-1-dependent internalization of the IFN-γR2 signaling chain. Here we show that human malignant T cells are also resistant to the growth inhibitory effect of both the IGF-1 receptor-specific inhibitor picropodophyllin (PPP) and retrovirus-mediated gene transfer of a dominant negative IGF-1 receptor. However, blockade of IGF-1 receptor perturbs IFN-γR2 internalization and induces its cell surface accumulation in malignant T cells. This allows the reinstatement of the IFN-γ-induced STAT1 activation, a high expression of proapoptotic molecules, and the suppression of malignant T-cell growth both in vitro and in vivo in a severe combined immunodeficiency (SCID) mouse model. These data indicate that the inhibition of IGF-1 signaling combined with IFN-γ administration could be a promising approach to suppress the growth of neoplastic T cells resistant to each treatment on its own.

Original languageEnglish
Pages (from-to)2496-2504
Number of pages9
JournalBlood
Volume109
Issue number6
DOIs
Publication statusPublished - Mar 15 2007

Fingerprint

T-cells
Cell growth
Somatomedins
Interferons
Somatomedin Receptors
T-Lymphocytes
STAT1 Transcription Factor
Growth
Severe Combined Immunodeficiency
Interferon Receptors
Gene transfer
Retroviridae
Transcriptional Activation
Tumors
Chemical activation
Cells
Molecules
Genes
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Conti, L., Regis, G., Longo, A., Bernabei, P., Chiarle, R., Giovarelli, M., & Novelli, F. (2007). In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth. Blood, 109(6), 2496-2504. https://doi.org/10.1182/blood-2006-07-034231

In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth. / Conti, Laura; Regis, Gabriella; Longo, Angela; Bernabei, Paola; Chiarle, Roberto; Giovarelli, Mirella; Novelli, Francesco.

In: Blood, Vol. 109, No. 6, 15.03.2007, p. 2496-2504.

Research output: Contribution to journalArticle

Conti, L, Regis, G, Longo, A, Bernabei, P, Chiarle, R, Giovarelli, M & Novelli, F 2007, 'In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth', Blood, vol. 109, no. 6, pp. 2496-2504. https://doi.org/10.1182/blood-2006-07-034231
Conti, Laura ; Regis, Gabriella ; Longo, Angela ; Bernabei, Paola ; Chiarle, Roberto ; Giovarelli, Mirella ; Novelli, Francesco. / In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth. In: Blood. 2007 ; Vol. 109, No. 6. pp. 2496-2504.
@article{068f8cc2afd241749c6d689240870085,
title = "In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth",
abstract = "Several approaches to target insulin-like growth factor-1 (IGF-1) signaling have resulted in the inhibition of the growth of a broad range of tumor cells. Malignant T cells are insensitive to the antiproliferative effects of the interferon-γ (IFN-γ)/signal transducer and activator of transcription 1 (STAT1) pathway because of the IGF-1-dependent internalization of the IFN-γR2 signaling chain. Here we show that human malignant T cells are also resistant to the growth inhibitory effect of both the IGF-1 receptor-specific inhibitor picropodophyllin (PPP) and retrovirus-mediated gene transfer of a dominant negative IGF-1 receptor. However, blockade of IGF-1 receptor perturbs IFN-γR2 internalization and induces its cell surface accumulation in malignant T cells. This allows the reinstatement of the IFN-γ-induced STAT1 activation, a high expression of proapoptotic molecules, and the suppression of malignant T-cell growth both in vitro and in vivo in a severe combined immunodeficiency (SCID) mouse model. These data indicate that the inhibition of IGF-1 signaling combined with IFN-γ administration could be a promising approach to suppress the growth of neoplastic T cells resistant to each treatment on its own.",
author = "Laura Conti and Gabriella Regis and Angela Longo and Paola Bernabei and Roberto Chiarle and Mirella Giovarelli and Francesco Novelli",
year = "2007",
month = "3",
day = "15",
doi = "10.1182/blood-2006-07-034231",
language = "English",
volume = "109",
pages = "2496--2504",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth

AU - Conti, Laura

AU - Regis, Gabriella

AU - Longo, Angela

AU - Bernabei, Paola

AU - Chiarle, Roberto

AU - Giovarelli, Mirella

AU - Novelli, Francesco

PY - 2007/3/15

Y1 - 2007/3/15

N2 - Several approaches to target insulin-like growth factor-1 (IGF-1) signaling have resulted in the inhibition of the growth of a broad range of tumor cells. Malignant T cells are insensitive to the antiproliferative effects of the interferon-γ (IFN-γ)/signal transducer and activator of transcription 1 (STAT1) pathway because of the IGF-1-dependent internalization of the IFN-γR2 signaling chain. Here we show that human malignant T cells are also resistant to the growth inhibitory effect of both the IGF-1 receptor-specific inhibitor picropodophyllin (PPP) and retrovirus-mediated gene transfer of a dominant negative IGF-1 receptor. However, blockade of IGF-1 receptor perturbs IFN-γR2 internalization and induces its cell surface accumulation in malignant T cells. This allows the reinstatement of the IFN-γ-induced STAT1 activation, a high expression of proapoptotic molecules, and the suppression of malignant T-cell growth both in vitro and in vivo in a severe combined immunodeficiency (SCID) mouse model. These data indicate that the inhibition of IGF-1 signaling combined with IFN-γ administration could be a promising approach to suppress the growth of neoplastic T cells resistant to each treatment on its own.

AB - Several approaches to target insulin-like growth factor-1 (IGF-1) signaling have resulted in the inhibition of the growth of a broad range of tumor cells. Malignant T cells are insensitive to the antiproliferative effects of the interferon-γ (IFN-γ)/signal transducer and activator of transcription 1 (STAT1) pathway because of the IGF-1-dependent internalization of the IFN-γR2 signaling chain. Here we show that human malignant T cells are also resistant to the growth inhibitory effect of both the IGF-1 receptor-specific inhibitor picropodophyllin (PPP) and retrovirus-mediated gene transfer of a dominant negative IGF-1 receptor. However, blockade of IGF-1 receptor perturbs IFN-γR2 internalization and induces its cell surface accumulation in malignant T cells. This allows the reinstatement of the IFN-γ-induced STAT1 activation, a high expression of proapoptotic molecules, and the suppression of malignant T-cell growth both in vitro and in vivo in a severe combined immunodeficiency (SCID) mouse model. These data indicate that the inhibition of IGF-1 signaling combined with IFN-γ administration could be a promising approach to suppress the growth of neoplastic T cells resistant to each treatment on its own.

UR - http://www.scopus.com/inward/record.url?scp=33947265626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947265626&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-07-034231

DO - 10.1182/blood-2006-07-034231

M3 - Article

VL - 109

SP - 2496

EP - 2504

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -